Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes

Endocrinology

Volumn 138, Issue 9, 1997, Pages 3779-3786

  Croston, Glenn E ^a   Milan, Loribelle B ^a   Marschke, Keith B ^a   Reichman, Melvin ^a   Briggs, Michael R ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIESTROGEN; BICALUTAMIDE; CLOMIFENE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; HORMONE RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; METRIBOLONE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PROGESTERONE; RALOXIFENE; TAMOXIFEN; TOREMIFENE;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DNA BINDING; ESTROGEN THERAPY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIGAND BINDING; LIPID BLOOD LEVEL; LIVER CELL CULTURE; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 0030857452     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.9.5404     Document Type: Article

References (11)

1. Castelli WP 1984 Epidemiology of coronary heart disease: The Framingham Study. Am J Med 76:4-12
2. Clarkson TB, Hughes CL, Klein KP 1995 The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease. Prog Cardiovasc Dis 3:189-193
3. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM 1991 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204
4. Lobo RA 1991 Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 73:925-930
5. Samsioe G 1994 Cardioprotection by estrogens: mechanisms of action-the lipids. Int J Fertil 39:43-49
6. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M 1993 Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328:1069-1075
7. Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D 1995 Estrogen replacment therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. Am J Epidemiol 142:1011-1019
8. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE 1992 Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 69:1176-178
9. Bush TL, Fried LP, Barrett-Connor E 1988 Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem 34:B60-B70
10. Barrett-Connor E, Bush TL 1991 Estrogen and coronary heart disease in women. JAMA 265:1861-1867
11. Grodstein F, Stampfer M 1995 The epidemiology of coronary heart disease and estrogen replacment in postmenopausal women. Prog Cardiovasc Dis 3:199-210